Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
- PMID: 25035633
- PMCID: PMC4097927
- DOI: 10.4103/0975-7406.130965
"VSports最新版本" Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues
"V体育官网入口" Abstract
Dendrimers are the emerging polymeric architectures that are known for their defined structures, versatility in drug delivery and high functionality whose properties resemble with biomolecules. These nanostructured macromolecules have shown their potential abilities in entrapping and/or conjugating the high molecular weight hydrophilic/hydrophobic entities by host-guest interactions and covalent bonding (prodrug approach) respectively. Moreover, high ratio of surface groups to molecular volume has made them a promising synthetic vector for gene delivery. Owing to these properties dendrimers have fascinated the researchers in the development of new drug carriers and they have been implicated in many therapeutic and biomedical applications VSports手机版. Despite of their extensive applications, their use in biological systems is limited due to toxicity issues associated with them. Considering this, the present review has focused on the different strategies of their synthesis, drug delivery and targeting, gene delivery and other biomedical applications, interactions involved in formation of drug-dendrimer complex along with characterization techniques employed for their evaluation, toxicity problems and associated approaches to alleviate their inherent toxicity. .
Keywords: Dendrimer; drug targeting; drug-dendrimer interactions; gene delivery; polyamidoamine. V体育安卓版.
Conflict of interest statement
Figures






VSports注册入口 - References
-
- Hu CM, Aryal S, Zhang L. Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv. 2010;1:323–34. - PubMed
-
- Northfelt DW, Dezube BJ, Thommes JA, Miller BJ, Fischl MA, Friedman-Kien A, et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: Results of a randomized phase III clinical trial. J Clin Oncol. 1998;16:2445–51. - PubMed
-
- Harries M, Ellis P, Harper P. Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. J Clin Oncol. 2005;23:7768–71. - PubMed
-
- Brannon-Peppas L, Blanchette JO. Nanoparticle and targeted systems for cancer therapy. Adv Drug Deliv Rev. 2004;56:1649–59. - PubMed (VSports app下载)
-
- Buhleier E, Wehner W, VÖGtle F. “Cascade”- and “nonskid-chain-like” a syntheses of molecular cavity topologies. Synthesis. 1978;2:155–8.
Publication types (V体育平台登录)
LinkOut - more resources
Full Text Sources
Other Literature Sources